Globus Medical: Q3 Earnings Insights
Portfolio Pulse from Benzinga Insights
Globus Medical (NYSE:GMED) reported Q3 earnings, beating estimated earnings by 5.56% with an EPS of $0.57 versus an estimate of $0.54. Revenue was up $129.49 million from the same period last year. Last quarter, the company beat on EPS by $0.04, which was followed by a 1.87% drop in the share price the next day.
November 07, 2023 | 9:25 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Globus Medical's Q3 earnings beat estimates, with an EPS of $0.57, up 5.56% from estimates. However, past performance shows a drop in share price following a beat on EPS.
Globus Medical's earnings beat estimates, which is generally a positive signal. However, the company's share price dropped after a similar beat last quarter, suggesting that the market may have already priced in the positive earnings news. Therefore, the short-term impact on the stock price is uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100